This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Diasorin Molecular LLC
DIA SORIN MOLECULAR LLC, a prominent player in the molecular diagnostics industry, is headquartered in the United States. Founded in 2008, the company has rapidly established itself as a leader in the development of innovative diagnostic solutions, particularly in the fields of infectious diseases and oncology. With a strong operational presence across North America and Europe, DiaSorin Molecular is renowned for its cutting-edge products, including the LIAISON® MDX platform, which offers unique, high-throughput testing capabilities. The company’s commitment to quality and accuracy has positioned it as a trusted partner in laboratories worldwide. Notable achievements include the successful launch of several FDA-cleared assays, reinforcing its reputation for excellence in molecular testing. With a focus on advancing healthcare through reliable diagnostics, DiaSorin Molecular continues to shape the future of the industry.
DitchCarbon Score
How does Diasorin Molecular LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Diasorin Molecular LLC's score of 36 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Diasorin Molecular LLC, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of DiaSorin S.p.A., which may influence its climate commitments and emissions reporting. As part of its corporate family, Diasorin Molecular LLC inherits emissions data and climate initiatives from DiaSorin S.p.A. at a cascade level of 2. However, no specific reduction targets or significant achievements have been documented for Diasorin Molecular LLC itself. The absence of documented reduction initiatives suggests that the company may still be in the process of establishing its own climate strategy. In the broader context, the parent company, DiaSorin S.p.A., may have its own climate commitments and targets, but these have not been detailed in the information provided. As such, Diasorin Molecular LLC's current climate commitments remain vague, and further information would be necessary to assess its specific carbon footprint and reduction strategies.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 3,223,720 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 8,426,130 | 00,000,000 | 00,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Diasorin Molecular LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
